<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="167995">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01683799</url>
  </required_header>
  <id_info>
    <org_study_id>RSRB00044088</org_study_id>
    <secondary_id>R21AG041942-01A1</secondary_id>
    <nct_id>NCT01683799</nct_id>
  </id_info>
  <brief_title>Sleep, Pain and Inflammatory Processes in Older Adults With Osteoarthritis</brief_title>
  <official_title>Slow Wave Sleep and Inflammatory Processes in Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Rochester</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Aging (NIA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Rochester</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose if the study is to determine whether improving sleep, especially slow wave or
      &quot;deep&quot; sleep, in older adults with osteoarthritis (OA) and insomnia reduces pain sensitivity
      and inflammatory responses to pain, and improves OA-related pain.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Anticipated">November 2014</completion_date>
  <primary_completion_date type="Anticipated">September 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>Change from baseline in minutes of time in slow wave sleep</measure>
    <time_frame>baseline and 10 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in relative power of delta EEG activity to index slow wave sleep activity</measure>
    <time_frame>baseline and 10 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in nociception flexion reflex threshold</measure>
    <time_frame>baseline and 10 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in electrocutaneous pain threshold</measure>
    <time_frame>baseline and 10 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in inflammatory cytokine responses to pain</measure>
    <time_frame>baseline and 10 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in Western Ontario and McMaster University OA Index</measure>
    <time_frame>baseline and 10 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in Knee Pain Scale score</measure>
    <time_frame>baseline and 10 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Osteoarthritis of the Knee</condition>
  <condition>Insomnia</condition>
  <condition>Knee Pain</condition>
  <arm_group>
    <arm_group_label>Insomnia treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cognitive Behavioral Therapy for Insomnia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cognitive Behavioral Therapy for Insomnia</intervention_name>
    <description>6-week behavioral treatment for insomnia</description>
    <arm_group_label>Insomnia treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  50-75 years of age (for women, post-menopausal)

          -  Kellgren-Lawrence grade II radiographic evidence of OA affecting one or both knees

          -  knee pain on most days for ≥ 6 months

          -  self-reported disability due to knee pain for ≥ 2 of the following: walking,
             kneeling, ascending or descending stairs, or performing daily activities

          -  willing and able to avoid all prescription and non-prescription, non-opiate pain
             medication for 48 hours prior to testing and all narcotic pain medication for 2 weeks
             prior to testing

          -  meets research diagnostic criteria for sleep maintenance insomnia

        Exclusion Criteria:

          -  health conditions with immunological components or undergoing or taking
             immunosuppressive therapies

          -  conditions contraindicated for or potentially limiting ability to conduct NFR and/or
             cold pressor test (e.g. Raynaud's syndrome; seizures; prior MI; respiratory
             conditions; leg/hip nerve damage; BMI ≥ 32)

          -  sleep disorders other than insomnia

          -  dementia or cognitive impairment

          -  history of schizophrenia or bipolar I disorder; current or recent history (within 3
             months) of major psychiatric disorders

          -  current depressive symptomatology or current suicidality

          -  active substance dependence

          -  untreated hypertension

          -  use of antidepressants (stable use for 3 months okay), antipsychotics, mood
             stabilizers, sedative-hypnotics, opiate analgesics
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kathi L. Heffner, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Rochester</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wilfred Pigeon, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Rochester</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kathi L. Heffner, PhD</last_name>
    <phone>585-273-4786</phone>
    <email>kathi_heffner@urmc.rochester.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Rochester Medical Center</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Kathi L. Heffner, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Wilfred Pigeon, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael Maloney, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christopher R. France, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 2, 2014</lastchanged_date>
  <firstreceived_date>September 7, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Rochester</investigator_affiliation>
    <investigator_full_name>Kathi Heffner</investigator_full_name>
    <investigator_title>Asst Professor</investigator_title>
  </responsible_party>
  <keyword>Osteoarthritis</keyword>
  <keyword>Insomnia</keyword>
  <keyword>Chronic pain</keyword>
  <keyword>Cognitive Behavioral Therapy for Insomnia</keyword>
  <keyword>Inflammation</keyword>
  <keyword>Inflammatory cytokines</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
    <mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
